Reason for request
Re-assessment of the Actual Benefit and Improvement in Actual Benefit for the symptomatic treatment of idiopathic restless legs syndrome (RLS at the request of the Committee (pursuant to article R 163-21 of the French Social Security Code).
Clinical Benefit
| Moderate |
Moderate in patients with very severe idiopathic RLS. |
Clinical Added Value
| minor |
SIFROL provides a minor improvement in actual benefit (IAB IV) in the management of patients with very severe idiopathic restless legs syndrome. |
eNq1mF1v2jAUhu/5FVHuSUhboJ0C1cbaDanVGC3atJvKJCdgltrpsc3Hfv0cQjc6Oepq8GVs5z0nPq8fHyW+XD/m3hJQUM56fhS0fA9YwlPKZj1/cn/dPPcv+414QZZkb1k3aAXRie8lORGi55ezwRQIE8H325uPoN8H9PsNL+bTBSTyxTolaR58JmJ+S4pyjRcvOU29R5Bznvb8QsntqBcLiTqL/orjT1GQBOJwN7I/u3g42x+Pw1LsP1SVALwhbGYUBWalmShEYHJAJMw4bmryPbXSpmIMgitMYETkfIR8SVNIjSEykguwCpKt0jvAZQ6yDGIUDxfJo7ASJwuyHsPT0Jz0ez07kGvZbDWjbrfd6rbPL066Zx2rULi3VeYq6I8Ik4fotN2JTjshsFAEM5pZVmbEUZLcUU2oGLy0laM4CE+v1j6losjJJliIwnarCBI9DagPv7sPKb/gHjWOcr1n/+gzlefhG7Oe7GDhKOOSRQOumKxhxvXYdiMGnElY11fUDnNyvfMiBXE82V+cmRE/UtOcJrZA08hRIORkPKzn2fFQ8IEImKA7FnyjLOUrcXzG7NfUUfbFFpNG0QLT6OHk4rwTtdvWR+iHNlDN7XKlkBcQavpQcQhUhizjh+JEe9Is9ezII5lx2+HwhORQ0+M0LbmiXfjckjnzubszVE0YRT9d3dua46sC3NxtH43SNO39KasddF2QXFuxNvG3G7s63066X4VmbsylLMS7MFytVsGciKYgepeCDI9M9b1r1F3n7eSurnqXioyOUp9WV97b6mN7zl67zQ/tUHfv7zphYwyJCg6oRYVkZ+AcXh2fxX/bU2dpj16ww12YbStJJOXMVZOjpkbFw+iv68quUQPiS5bRmj8htb6Mw+ovTL8Rh+UfmH7jN3XR4Ew=
HA5SD4bAtExq4Cwk
